|
|
Post by cgiscgis on Jan 29, 2016 10:54:40 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 29, 2016 10:58:44 GMT -5
We can't read your mind you need to post it please |
|
|
|
Post by peppy on Jan 29, 2016 10:59:46 GMT -5
|
|
|
|
Post by lakers on Jan 31, 2016 14:33:57 GMT -5
Mack-Cali announces new lease with Ascensia Diabetes Care Global Leader in Blood Glucose Monitoring and Diabetes Care Solutions will Open U.S. Headquarters in Parsippany, NJ By Frank Cahill - Jan 29, 2016 parsippanyfocus.com/2016/01/29/mack-cali-announces-new-lease-with-ascensia-diabetes-care/Mayor is proud to announce for the 39th consecutive year, Parsippany has been named a Tree City. ... NJ Patch has put together a list of the "15 Safest Big Towns" in New Jersey and Parsippany-Troy Hills ranks among the top five. KKR, Panasonic form newco Ascensia from Bayer Diabetes buy for $1.1B Panasonic Healthcare has closed its purchase of the Bayer Diabetes Care business for about $1.1 billion. The deal was originally disclosed in June and was funded in part by well-known hedge fund KKR, which holds 80% of Panasonic Healthcare with the remainder owned by the larger Panasonic corporate entity. The acquired business will operate as a stand-alone company known as Ascensia Diabetes Care. Along with Panasonic Healthcare, the newco is expected to continue to develop, manufacture and market blood glucose monitoring meters and strips globally. "Our goal is to ensure high-quality technologies and diabetes care solutions are available to all patients who need them. Bringing together Panasonic Healthcare and Ascensia Diabetes Care will significantly help to achieve this goal," said the President of Panasonic Healthcare Hidehito Kotani in a statement. Sign up for our FREE newsletter for more news like this sent to your inbox! He continued, "Together with KKR, the companies will be able to serve more patients in more places across the globe with world-class products. We greatly look forward to expanding this business and innovating new solutions at this integral point in the diabetes care industry." The Bayer Diabetes Care Business had €909 million ($1 billion) in 2014 sales, with the business primarily driven by sales of the Contour blood glucose monitor products. Ascencia will be headed by Michael Kloss, the head of Bayer Diabetes Care since 2013. The company sells products in 125 countries worldwide; it will have about 1,400 employees in 38 countries after the close of the deal in all the countries. A staggering 9% of the global population has diabetes, according to the latest World Health Organization estimate, and in many poorer nations it is uncommon for diabetic patients to self-monitor blood glucose levels. KKR and Panasonic likely are betting that the relatively inexpensive blood glucose monitors marketed by Bayer could change all that, appealing to the ever-growing diabetic population. An estimated 1.5 million deaths were attributed to diabetes in 2012, with more than 80% of those occurring in low- and middle- income countries. Earlier this year, competitor Abbott ($ABT) offered a slightly different approach to address the same issue. It launched a physician blood glucose monitor in India that works via a quarter-sized sensor attached to the back of a diabetic patient's arm that is reapplied every 2 weeks and records data every 15 minutes. Ascensia is focused on global growth but innovation won't be entirely off the table. "It has a strong pipeline and will continue to invest in research and development of new products that will help to improve patient care," concluded KKR Europe, Africa and Middle East Head Johannes Huth. www.fiercemedicaldevices.com/story/kkr-panasonic-form-newco-ascensia-bayer-diabetes-buy-11b/2016-01-06Indeed.com Ascensia Diabetes Care - Whippany, NJ .... opening a second location in New Jersey Feb 2016. www.indeed.com/m/jobs?sameL=1&q=Ascensia+Diabetes+Care&l=Whippany%2C+NJ&from=searchOnSerpGoogle "ascensia diabetes care feb 2016" |
|
|
|
Post by jpg on Jan 31, 2016 14:41:34 GMT -5
Mack-Cali announces new lease with Ascensia Diabetes Care Global Leader in Blood Glucose Monitoring and Diabetes Care Solutions will Open U.S. Headquarters in Parsippany, NJ By Frank Cahill - Jan 29, 2016 parsippanyfocus.com/2016/01/29/mack-cali-announces-new-lease-with-ascensia-diabetes-care/Mayor is proud to announce for the 39th consecutive year, Parsippany has been named a Tree City. ... NJ Patch has put together a list of the "15 Safest Big Towns" in New Jersey and Parsippany-Troy Hills ranks among the top five. KKR, Panasonic form newco Ascensia from Bayer Diabetes buy for $1.1B Panasonic Healthcare has closed its purchase of the Bayer Diabetes Care business for about $1.1 billion. The deal was originally disclosed in June and was funded in part by well-known hedge fund KKR, which holds 80% of Panasonic Healthcare with the remainder owned by the larger Panasonic corporate entity. The acquired business will operate as a stand-alone company known as Ascensia Diabetes Care. Along with Panasonic Healthcare, the newco is expected to continue to develop, manufacture and market blood glucose monitoring meters and strips globally. "Our goal is to ensure high-quality technologies and diabetes care solutions are available to all patients who need them. Bringing together Panasonic Healthcare and Ascensia Diabetes Care will significantly help to achieve this goal," said the President of Panasonic Healthcare Hidehito Kotani in a statement. Sign up for our FREE newsletter for more news like this sent to your inbox! He continued, "Together with KKR, the companies will be able to serve more patients in more places across the globe with world-class products. We greatly look forward to expanding this business and innovating new solutions at this integral point in the diabetes care industry." The Bayer Diabetes Care Business had €909 million ($1 billion) in 2014 sales, with the business primarily driven by sales of the Contour blood glucose monitor products. Ascencia will be headed by Michael Kloss, the head of Bayer Diabetes Care since 2013. The company sells products in 125 countries worldwide; it will have about 1,400 employees in 38 countries after the close of the deal in all the countries. A staggering 9% of the global population has diabetes, according to the latest World Health Organization estimate, and in many poorer nations it is uncommon for diabetic patients to self-monitor blood glucose levels. KKR and Panasonic likely are betting that the relatively inexpensive blood glucose monitors marketed by Bayer could change all that, appealing to the ever-growing diabetic population. An estimated 1.5 million deaths were attributed to diabetes in 2012, with more than 80% of those occurring in low- and middle- income countries. Earlier this year, competitor Abbott ($ABT) offered a slightly different approach to address the same issue. It launched a physician blood glucose monitor in India that works via a quarter-sized sensor attached to the back of a diabetic patient's arm that is reapplied every 2 weeks and records data every 15 minutes. Ascensia is focused on global growth but innovation won't be entirely off the table. "It has a strong pipeline and will continue to invest in research and development of new products that will help to improve patient care," concluded KKR Europe, Africa and Middle East Head Johannes Huth. www.fiercemedicaldevices.com/story/kkr-panasonic-form-newco-ascensia-bayer-diabetes-buy-11b/2016-01-06What is the connection to Afrezza? Thank you, |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 31, 2016 14:59:21 GMT -5
Mack-Cali announces new lease with Ascensia Diabetes Care Global Leader in Blood Glucose Monitoring and Diabetes Care Solutions will Open U.S. Headquarters in Parsippany, NJ By Frank Cahill - Jan 29, 2016 parsippanyfocus.com/2016/01/29/mack-cali-announces-new-lease-with-ascensia-diabetes-care/Mayor is proud to announce for the 39th consecutive year, Parsippany has been named a Tree City. ... NJ Patch has put together a list of the "15 Safest Big Towns" in New Jersey and Parsippany-Troy Hills ranks among the top five. KKR, Panasonic form newco Ascensia from Bayer Diabetes buy for $1.1B Panasonic Healthcare has closed its purchase of the Bayer Diabetes Care business for about $1.1 billion. The deal was originally disclosed in June and was funded in part by well-known hedge fund KKR, which holds 80% of Panasonic Healthcare with the remainder owned by the larger Panasonic corporate entity. The acquired business will operate as a stand-alone company known as Ascensia Diabetes Care. Along with Panasonic Healthcare, the newco is expected to continue to develop, manufacture and market blood glucose monitoring meters and strips globally. "Our goal is to ensure high-quality technologies and diabetes care solutions are available to all patients who need them. Bringing together Panasonic Healthcare and Ascensia Diabetes Care will significantly help to achieve this goal," said the President of Panasonic Healthcare Hidehito Kotani in a statement. Sign up for our FREE newsletter for more news like this sent to your inbox! He continued, "Together with KKR, the companies will be able to serve more patients in more places across the globe with world-class products. We greatly look forward to expanding this business and innovating new solutions at this integral point in the diabetes care industry." The Bayer Diabetes Care Business had €909 million ($1 billion) in 2014 sales, with the business primarily driven by sales of the Contour blood glucose monitor products. Ascencia will be headed by Michael Kloss, the head of Bayer Diabetes Care since 2013. The company sells products in 125 countries worldwide; it will have about 1,400 employees in 38 countries after the close of the deal in all the countries. A staggering 9% of the global population has diabetes, according to the latest World Health Organization estimate, and in many poorer nations it is uncommon for diabetic patients to self-monitor blood glucose levels. KKR and Panasonic likely are betting that the relatively inexpensive blood glucose monitors marketed by Bayer could change all that, appealing to the ever-growing diabetic population. An estimated 1.5 million deaths were attributed to diabetes in 2012, with more than 80% of those occurring in low- and middle- income countries. Earlier this year, competitor Abbott ($ABT) offered a slightly different approach to address the same issue. It launched a physician blood glucose monitor in India that works via a quarter-sized sensor attached to the back of a diabetic patient's arm that is reapplied every 2 weeks and records data every 15 minutes. Ascensia is focused on global growth but innovation won't be entirely off the table. "It has a strong pipeline and will continue to invest in research and development of new products that will help to improve patient care," concluded KKR Europe, Africa and Middle East Head Johannes Huth. www.fiercemedicaldevices.com/story/kkr-panasonic-form-newco-ascensia-bayer-diabetes-buy-11b/2016-01-06What is the connection to Afrezza? Thank you, same Q.. all they have is contour meters? |
|
|
|
Post by cgiscgis on Jan 31, 2016 15:04:47 GMT -5
I posted about Ascensia earlier. They reason this is interesting is the location: Parsippany, NJ
First diabetes care center to run with Afrezza will open somewhere in New Jersey this quarter.
|
|
|
|
Post by cgiscgis on Jan 31, 2016 15:08:13 GMT -5
parsippanyfocus.com/2016/01/29/mack-cali-announces-new-lease-with-ascensia-diabetes-care/Mack-Cali announces new lease with Ascensia Diabetes Care PARSIPPANY — Mack-Cali Realty Corporation announced that Ascensia Diabetes Care US, Inc., a leader in blood glucose monitoring that is owned by Panasonic Healthcare Holdings Co., Ltd. and leading global investment firm KKR, will bring their U.S. headquarters to Five Wood Hollow Road. Ascensia signed a lease for 43,534 square feet for over 10 years. The award-winning Mack-Cali property is a 317,040-square-foot, three-story, class A office building in Morris County with easy highway access, a sophisticated infrastructure, and outstanding amenities. Ascensia joins AIG, Coyne PR, Groupe SEB, The MI Group, and Decision Resources to bring this trophy asset to 98.6 percent leased. “This building is the ideal home for Ascensia’s U.S. headquarters, providing all the conveniences and services a company of this significance needs,” said Christopher DeLorenzo, Mack-Cali executive vice president of leasing. “Mack-Cali’s strategic plan focuses on our core properties like Five Wood Hollow Road that bring together premier office space, ideal transportation options, and the amenities to create workplaces where employees want to work.” Strategically located and beautifully renovated, Five Wood Hollow Road is LEED Gold certified by the U.S. Green Building Council. It is located at the nexus of I-287 and I-80, with I-280, and routes 202, 46, and 10 all nearby, giving tenants easy commuting access. The building boasts a range of amenities including a contemporary, three-story renovated atrium lobby, an on-site, full-service cafeteria with indoor and outdoor seating, complimentary Wi-Fi available in the cafeteria and its adjacent public meeting rooms, as well as on-site property management. The building is wired with fiber optics for high-speed connectivity and features a recently upgraded high-efficiency HVAC system. In addition, further 2016 planned upgrades include a new, state-of-the-art fitness center and renovated cafe and conference center. “Bringing a company like Ascensia to our township is validation of the business-friendly environment we are cultivating here that brings a significant and positive economic impact,” said Parsippany Mayor James R. Barberio. “We welcome the new jobs and look forward to Ascensia calling Parsippany home for a long time to come.” Ascensia was represented in the transaction by Roby Bull and Steven Rotter, both of Jones Lang LaSalle. Mack-Cali was represented in-house by Brian Decillis, vice president of leasing. About Mack-Cali Realty Corporation Mack-Cali Realty Corporation is a fully integrated, self-administered, self-managed real estate investment trust (REIT) providing management, leasing, development, and other tenant-related services for its two-platform operations of waterfront and transit-based office and luxury multi-family assets. Mack-Cali owns or has interests in 276 properties, consisting of 148 office and 109 flex properties totaling approximately 30 million square feet and 19 multi-family rental properties containing approximately 5,700 residential units and a pipeline of 10,000 units, all located in the Northeast. Mack-Cali strives to provide its tenants and residents with the most innovative communities that empower them to re-imagine the way they work and live. Additional information on Mack-Cali Realty Corporation and the commercial real estate properties and multi-family residential communities available for lease can be found on the Company’s website at www.mack-cali.com.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 31, 2016 15:15:46 GMT -5
I posted about Ascensia earlier. They reason this is interesting is the location: Parsippany, NJ First diabetes care center to run with Afrezza will open somewhere in New Jersey this quarter. Novartis and GSK? |
|
|
|
Post by cgiscgis on Jan 31, 2016 15:23:16 GMT -5
Panasonic?
|
|
|
|
Post by lakers on Jan 31, 2016 17:12:06 GMT -5
The CEO said he was also optimistic about an unrelated venture by a private firm that is looking to create a diabetes care center business model that can provide in-house services to urgent care centers throughout the country. The venture, he said, is bullish on Afrezza and is planning to use the drug as its top treatment for the disorder. The first center is expected to open next month in New Jersey. “They’ve coined the term ‘real time diabetes management, powered by Afrezza,’” Pfeffer said. “This is an excellent opportunity for us and it takes no money at all from MannKind.” In the meantime, Pfeffer noted that discussions are already underway with prospective partners in various regions across the globe who were interested in Afrezza prior to the selection of Sanofi. Any partnerships, he said, could come with some upfront cash that could help the company’s financial situation. Read more: mnkd.proboards.com/thread/4920/danbury-times-mnkd-partner-private#ixzz3yrLpl68uPrivate equity KKR owns 80% of Panasonic Healthcare. For Matt to say it cost nothing, the private firm's investors could own a % of Mannkind. There is no free dinner. BR owns 4.6%, Al owns ~ 37%, if KKR owns 10%, together they could LBO Afrezza which would provide sufficient funding for TS. NURTURING POSITIVE PARTNERSHIPS At Ascensia Diabetes Care we appreciate the power of mutually beneficial partnerships. Such collaborations have contributed significantly in the development of groundbreaking products and technologies and also increased our knowledge of diabetes and its management. Our technology and innovation partners help us to explore new ways of delivering cutting-edge diabetes management solutions. We also work closely with healthcare professionals, academic institutions, and patient groups around the world to ensure that the requirements of people with diabetes are central to everything we do. For example, our exclusive international alliance with Medtronic, Inc. is vital to the development of innovative next-generation diabetes management solutions. Through this collaboration the Ascensia Diabetes Care CONTOUR™NEXT LINK and CONTOUR™PLUS LINK meters allow seamless integration to the MiniMed® range of insulin pump systems, transmitting blood glucose results wirelessly to the insulin pump. Click here for further information on the CONTOUR™NEXT LINK and CONTOUR™PLUS LINK meters. ascensia.com/Partners/ |
|
|
|
Post by dictatorsaurus on Jan 31, 2016 17:42:25 GMT -5
A source informed me the plan was to open the center in Feb/Mar in NJ. This aligns with that plan. Once they open I'll drive down there and get as much information as possible. I have friends and relatives that are diabetic so I will definitely have lots of questions.
|
|
|
|
Post by agedhippie on Jan 31, 2016 17:54:02 GMT -5
I work for a company on that campus. I very much doubt that the clinic will be there, it's not a good location. There are a lot of big pharmaceutical companies in the immediate area (including JnJ) so I would not read anything into this.
|
|
|
|
Post by tayl5 on Jan 31, 2016 19:10:42 GMT -5
Might as well keep the dots coming. Maybe Matt P will connect a few on Wednesday. Our sleuths will look like Sherlocks and we can justify reading all these bits and speculations.
|
|
|
|
Post by bradleysbest on Jan 31, 2016 19:19:52 GMT -5
So far none of the dots I have connected amounted to anything. Keep hope alive!
|
|
